Showing results (21-30 of 89) with videos related to

Sort By:
Pageof 9
Cancers|October 27, 2022
A Phase I Dose-Escalation and Dose-Expansion Study of FCN-437c, a Novel CDK4/6 Inhibitor, in Patients with Advanced Solid TumorsAmita Patnaik, Erika Hamilton, Yan Xing, et al.
Nature Communications|December 17, 2025
ER degradation for ER+/HER2- advanced or metastatic breast cancer: a phase 1 trialErika Hamilton, Rachel M Layman, David Cosgrove, et al.
Cancer Treatment Reviews|May 5, 2023
Novel endocrine therapies: What is next in estrogen receptor positive, HER2 negative breast cancer?Chiara Corti, Carmine De Angelis, Giampaolo Bianchini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2025
Timing of Recurrence After Neoadjuvant Chemo-Immunotherapy in Early-Stage Triple-Negative Breast CancerLuca Licata, Marco Mariani, Giulia Viale, et al.
Clinical Breast Cancer|September 27, 2021
A First-in-Human Phase 1 Study of a Novel Selective Androgen Receptor Modulator (SARM), RAD140, in ER+/HER2- Metastatic Breast CancerPatricia LoRusso, Erika Hamilton, Cynthia Ma, et al.
Gynecologic Oncology|June 10, 2020
Tamrintamab pamozirine (SC-003) in patients with platinum-resistant/refractory ovarian cancer: Findings of a phase 1 studyErika Hamilton, David M O'Malley, Roisin O'Cearbhaill, et al.
Breast Cancer Research and Treatment|July 13, 2022
nextMONARCH Phase 2 randomized clinical trial: overall survival analysis of abemaciclib monotherapy or in combination with tamoxifen in patients with endocrine-refractory HR + , HER2- metastatic breast cancerErika Hamilton, Javier Cortes, Ozgur Ozyilkan, et al.
The Oncologist|June 15, 2022
Ovarian Function Suppression: A Deeper Consideration of the Role in Early Breast Cancer and its Potential Impact on Patient Outcomes: A Consensus Statement from an International Expert PanelBolivar Arboleda, Rupert Bartsch, Evandro de Azambuja, et al.
Gynecologic Oncology|July 28, 2024
Vaccination with folate receptor-alpha peptides in patients with ovarian cancer following response to platinum-based therapy: A randomized, multicenter clinical trialAditi Gupta, Roisin E O'Cearbhaill, Matthew S Block, et al.
NPJ Breast Cancer|December 4, 2025
Optimizing clinical monitoring and management guidelines for capivasertib in HR-positive/HER2-negative advanced breast cancer: expert opinionNeil M Iyengar, Joyce A O'Shaughnessy, Heather B Moore, et al.
Pageof 9